Organoids and AI-integrated models in ovarian cancer research: the future of personalized therapy
Anuradha Nikam, Gyamcho Tshering Bhutia, Sinjini Sarkar · 2026
Read Organoids and AI-integrated models in ovarian cancer research: the future of personalized therapy by Anuradha Nikam, Gyamcho Tshering Bhutia, Sinjini Sarkar (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623671.txt.
Description
Anuradha Nikam, Gyamcho Tshering Bhutia, and Sinjini Sarkar review two fast-moving tools in ovarian cancer research in a 2026 paper. Ovarian cancer is the deadliest gynecological cancer, marked by fast spread, great variety between tumors, and resistance to drugs. Organoids, mini-tumors grown from a patient's own tissue, can model her disease and test drugs in the lab.
Those models pour out complex data from images, gene reads, and drug tests. Artificial intelligence methods can sort that data to sharpen prognosis and predict which treatment will work. The review covers how organoids are built and how AI reads them. The authors stress that clinical use will need multi-center validation, shared methods, and trials that prove real gains for patients.
Catalog record
| CREATOR | Anuradha Nikam, Gyamcho Tshering Bhutia, Sinjini Sarkar |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |